AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3107495
Drug: Propranolol (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (320 mg)
Trial: 29799344
Drug: Ketamine (0.85
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.85 mg/kg/hr)
Trial: 29799344
Drug: Ketamine (0.70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.70 mg/kg/hr)
Trial: 15039245
Drug: 2 x
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 x 300 mg bupropion (BUP)
Trial: 11755834
Drug: Unoprostone 0.15%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unoprostone 0.15% twice daily
Trial: 15036568
Drug: Betaxolol 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 0.5% twice daily
Trial: 28387927
Drug: LDCT (Low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDCT (Low Dose Computed Tomography)
Trial: 25869689
Drug: Glucomannan (GNN)
DrugBank: Konjac mannan (DB14963)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucomannan (GNN) at a dose of 3 g/day for 3 months
Trial: 25869689
Drug: Placebo (maltodextrin)
RxNorm normalized name: Maltodextrin
DrugBank: Maltodextrin (DB12583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (maltodextrin) at a dose of 3 g/day for 3 months
Trial: 23713521
Drug: Tafluprost 0.0015%
RxNorm normalized name: TAFLUPROST 0.0015% OPH SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tafluprost 0.0015% (Saflutan®) once daily
Trial: 17160649
Drug: Patient-controlled analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled analgesia (PCA) using morphine
Trial: 1946567
Drug: Sensory cues
RxNorm normalized name: aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sensory cues of cigarette smoking (with minimal nicotine, 0.5 mg)
Trial: 1946567
Drug: Cigarette smoke
RxNorm normalized name: cigarette smoke
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarette smoke containing 0.5 mg of nicotine
Trial: 6756019
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg morphine administered epidurally
Trial: 6756019
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg morphine administered epidurally
Trial: 29281868
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (10 sessions of group therapy)
Trial: 15974220
Drug: Battery-powered toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Battery-powered toothbrush (Oral-B Kids)
Trial: 10492405
Drug: Bupivacaine 5
RxNorm normalized name: Sure-Amp BUPivacaine 5 MG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 5 mg/ml (200 mg)
Trial: 8922653
Drug: Ibandronate 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 5.0 mg
Trial: 8922653
Drug: Ibandronate 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 0.25 mg
Trial: 31353302
Drug: Single-injection ISB
RxNorm normalized name: ISB 1342
DrugBank: ISB 1342 (DB17251)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-injection ISB
Trial: 26758502
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FO) supplementation (5 ml/d, 1.2 g/d n-3 long-chain PUFA)
Trial: 20597040
Drug: Inhalation using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation using the Pari sinus device
Trial: 12171453
Drug: Nutrient‐dense protein‐energy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrient‐dense protein‐energy liquid supplement and encouragement to improve intake from other foods
Trial: 2073488
Drug: Oral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam (10 mg)
Trial: 8138958
Drug: Morphine (20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (20, 40 and 60 mg)
Trial: 1376362
Drug: Naloxone (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.1 and 0.2 mg)
Trial: 31846499
Drug: rESWT on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rESWT on agonist muscles (B)
Trial: 20806703
Drug: Immediate preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate preparation with resin AH26 sealer
Trial: 20806703
Drug: Delayed preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed preparation with resin AH26 sealer
Trial: 20806703
Drug: Immediate preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate preparation with ZOE Dorifil sealer
Trial: 20806703
Drug: Delayed preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed preparation with ZOE Dorifil sealer
Trial: 15126715
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g x d of mixed CLA isomers for 8 wk
Trial: 9512220
Drug: Gonadotrophin‐releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gonadotrophin‐releasing hormone agonist (GnRHa) and human menopausal gonadotrophin (HMG)
Trial: 21904641
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) supplementation at 1,200 mg daily for 7 days
Trial: 2965374
Drug: Treatment B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment B: 6 mg/kg/day at 07.00 h and 6 mg/kg/day at 19.00 h
Trial: 2965374
Drug: Treatment C:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment C: 4 mg/kg/day at 07.00 h and 8 mg/kg/day at 19.00 h
Trial: 24642580
Drug: Standard Triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Triple Therapy (STT) - 10 days of treatment with esomeprazole, amoxicillin, and clarithromycin
Trial: 24642580
Drug: Sequential Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential Therapy (SQT) - 5 days of esomeprazole and amoxicillin, followed by 5 days of esomeprazole, clarithromycin, and tinidazole
Trial: 24642580
Drug: Sequential Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential Therapy (SQT) with isolated CLA-R
Trial: 24642580
Drug: Sequential Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential Therapy (SQT) with isolated MET-R
Trial: 19527380
Drug: Daily iron
RxNorm normalized name: Walgreens Multivitamin One Daily Iron-Free Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron (III)-hydroxide polymaltose complex (Group III, n = 30)
Trial: 16238560
Drug: Tramadol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (1 mg.kg(‐1) loading dose, 0.2 mg.kg(‐1) bolus doses)
Trial: 16238560
Drug: Morphine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.1 mg.kg(‐1) loading dose, 0.02 mg.kg(‐1) bolus doses)
Trial: 12668406
Drug: Exposure therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure therapy alone
Trial: 11883725
Drug: Post-treatment sense
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment sense of control/internal attribution
Trial: 1971516
Drug: Terfenadine 120
RxNorm normalized name: terfenadine 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 120 mg once daily
Trial: 31233135
Drug: Home-based telerehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based telerehabilitation (TR) system, 36 sessions of arm motor therapy plus stroke education, 70 minutes each session.
Trial: 31233135
Drug: In-clinic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-clinic therapy (IC), 36 sessions of arm motor therapy plus stroke education, 70 minutes each session.
Trial: 3906162
Drug: Travasorb‐Hepatic (BCAA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Travasorb‐Hepatic (BCAA rich supplement)
Trial: 3906162
Drug: Ensure (casein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ensure (casein based supplement)
Trial: 31591739
Drug: Low-dose decitabine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose decitabine
Trial: 25877498
Drug: Brodalumab 70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brodalumab 70 mg
Trial: 15679722
Drug: Loteprednol etabonate
RxNorm normalized name: Loteprednol Etabonate
DrugBank: Loteprednol etabonate (DB14596)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Loteprednol etabonate 400 microg nasal spray
Trial: 15679722
Drug: Loteprednol etabonate
RxNorm normalized name: Loteprednol Etabonate
DrugBank: Loteprednol etabonate (DB14596)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Loteprednol etabonate 200 microg nasal spray
Trial: 14532926
Drug: RBC-C (ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC-C (ranitidine bismuth citrate 400 mg plus clarithromycin 500 mg)
Trial: 14532926
Drug: OCA (omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OCA (omeprazole 20 mg, clarithromycin 500 mg and amoxicillin 1000 mg)
Trial: 6724467
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline therapy (193.2 mg Theophyllinmonohydrat)
Trial: 6724467
Drug: Systemic application
RxNorm normalized name: Vaginal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic application (46.8 mg Aethylendiamin as Euphyllin)
Trial: 29863694
Drug: Mexidol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mexidol (200 mg intravenously for 10 days, then 2 tablets 0.125 mg twice a day for 8 weeks)
Trial: 10726785
Drug: Fortified gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified gentamicin ointment (1.5%)
Trial: 10726785
Drug: Both ointment
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both ointment and drops
Trial: 31362729
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of flipped classroom with problem-based learning (CG)
Trial: 30107042
Drug: Calcium citrate
RxNorm normalized name: Calcium Citrate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium citrate (1200 mg elementary calcium/daily)
Trial: 30107042
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (1200 mg elementary calcium/daily)
Trial: 16027399
Drug: Intravenous epoetin
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous epoetin alfa administration
Trial: 16027399
Drug: Subcutaneous epoetin
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous epoetin alfa administration
Trial: 9880451
Drug: rhu GM‐CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhu GM‐CSF (8 microg/kg/d), administered intravenously over 2 hours daily for 7 days and every other day for 21 days
Trial: 7720346
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (n = 25)
Trial: 23077973
Drug: Bedtime therapy
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime therapy with at least one hypertension medication
Trial: 24708031
Drug: Indacaterol (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol (150 μg once daily)
Trial: 18825368
Drug: AVP response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: AVP response in patients with chronic angiotensin-converting enzyme inhibitor therapy
Trial: 17052901
Drug: Albuterol (7.5mg/h)
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (7.5mg/h)
Trial: 15288384
Drug: Trexan without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trexan without amino-acid therapy
Trial: 11594942
Drug: Antioxidants plus
RxNorm normalized name: Homosalate 100 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 40 mg in 1 mL TOPICAL CREAM [LOreal Paris Age Perfect Radiant Foundation Broad Spectrum SPF 50 Sunscreen with Antioxidants plus Concentrated Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidants plus zinc (vitamin C 500 mg, vitamin E 400 IU, beta carotene 15 mg, zinc 80 mg)
Trial: 11594942
Drug: Zinc alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc alone (80 mg)
Trial: 27716324
Drug: Sarilumab 150
RxNorm normalized name: SARILUMAB 150MG/1.14ML INJ SYR 1.14ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarilumab 150 mg every 2 weeks (q2w)
Trial: 23299383
Drug: Daily doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily doses of 400 IU of vitamin E and 200 µg of selenium
Trial: 23297680
Drug: RTS,S/AS02(D) vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS02(D) vaccine
Trial: 10969114
Drug: Click test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Click test for surfactant therapy
Trial: 10969114
Drug: Usual clinical
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual clinical and chest radiograph criteria for surfactant therapy
Trial: 6379345
Drug: Diclofensine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofensine (2 X 25 mg/day for 30 days)
Trial: 20174642
Drug: Community-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community-based treatment by Health Extension Workers (HEWs)
Trial: 20174642
Drug: Community-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community-based treatment by HEWs
Trial: 20174642
Drug: Involving HEWs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Involving HEWs in TB treatment
Trial: 14563144
Drug: 700‐cGy external‐beam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 700‐cGy external‐beam irradiation to the operative site 24 hours prior to reexploration and decompressive treatment
Trial: 12734710
Drug: Kennedy ligament
RxNorm normalized name: human ligament preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kennedy ligament augmentation device (LAD)
Trial: 8896099
Drug: No augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No augmentation (non-augmented knee group)
Trial: 2050831
Drug: HCTZ 50
RxNorm normalized name: HCTZ 50 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCTZ 50 mg daily
Trial: 6084123
Drug: guanabenz 16
RxNorm normalized name: guanabenz 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: guanabenz 16 mg/hydrochlorothiazide 25 mg (combination tablet)
Trial: 31722312
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection with E0302 50 mg, twice a week for 16 weeks
Trial: 23480216
Drug: PEG 3350+E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG 3350+E (26 g split dose daily)
Trial: 23480216
Drug: Prucalopride (1-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride (1-2 mg daily)
Trial: 15107913
Drug: EDTA-T gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EDTA-T gel (pH 7.0) at concentrations of 5%, 10%, 15%, 20%, and 24% (n = 100)
Trial: 15107913
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (saline solution, n = 20)
Trial: 11707790
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl (EF) - 17 mL of 2% lidocaine plus 100 microg fentanyl
Trial: 24139497
Drug: Leukotriene Receptor
RxNorm normalized name: Leukotriene receptor antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukotriene Receptor Antagonist and Inhaled Corticosteroid
Trial: 23497032
Drug: Moxibustion treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxibustion treatment at 6 standard acupuncture points (ST36, ST35, ST34, SP9, Ex‐LE04, and SP10) 3 times per week for 4 weeks (total of 12 sessions)
Trial: 16546850
Drug: TMD treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMD treatment
Trial: 29370120
Drug: VMP (dietary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VMP (dietary multivitamin, multimineral and phytonutrient supplement)
Trial: 24874533
Drug: Transforaminal corticosteroid
RxNorm normalized name: transforming growth factor beta 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transforaminal corticosteroid injections
Trial: 2933253
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ketanserin
Trial: 30443883
Drug: Ultrasound (US)
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound (US) treatment and Transcutaneous Nerve Stimulation (TENS) plus exercise
Trial: 26063002
Drug: Quaternary ammonium
RxNorm normalized name: Quaternary ammonium compound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quaternary ammonium compound-based sanitizing wipe used at least once per day
Trial: 3845028
Drug: 0.05 mg
RxNorm normalized name: biotin 0.05 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mg Sulprostone gel
Trial: 3845028
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg Sulprostone gel
Trial: 26523885
Drug: 7-module internet-delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-module internet-delivered cognitive behavioral therapy (iCBT) program
Trial: 23348981
Drug: Glutamine supplementation
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine supplementation (3000 mg per day)
Trial: 12862363
Drug: Cyclical etidronate
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyclical etidronate (200 mg daily for 2 weeks every 3 months) for 18 months
Trial: 12862363
Drug: Cyclical etidronate
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyclical etidronate for 12 months followed by alendronate (5 mg daily) for 6 months
Trial: 10547251
Drug: Amoxicillin/clavulanate (Augmentin)
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (Augmentin) 45 mg/kg/d in 2 divided doses for 10 days
Trial: 10547251
Drug: Azithromycin (Zithromax),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (Zithromax), 10 mg/kg on the first day, followed by 5 mg/kg daily for 4 days
Trial: 1885826
Drug: Topical 2%
RxNorm normalized name: menthol topical 2% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2% lidocaine jelly
Trial: 6889218
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (propranolol + nifedipine)
Trial: 24285582
Drug: Extended-release (ER)
RxNorm normalized name: Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release (ER) niacin
Trial: 24408212
Drug: Varenicline (active
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (active medication)
Trial: 20028707
Drug: Fingolimod 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fingolimod 1.25 mg, once daily
Trial: 20028707
Drug: Fingolimod 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fingolimod 5.0 mg, once daily (switched to 1.25 mg during months 15-24)
Trial: 16871270
Drug: Open-label sildenafil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label sildenafil (50 mg adjustable to 100 mg)
Trial: 12015689
Drug: Cefazolin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (2 g iv) plus probenecid (1 g by mouth)
Trial: 12015689
Drug: Ceftriaxone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (1 g iv) plus oral placebo
Trial: 10506666
Drug: Corticotropin-releasing-hormone (CRH)
RxNorm normalized name: corticotropin-releasing hormone
DrugBank: Corticorelin (DB05394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticotropin-releasing-hormone (CRH) 100 microg (i.v.)
Trial: 10506666
Drug: Corticotropin-releasing-hormone (CRH)
RxNorm normalized name: corticotropin-releasing hormone
DrugBank: Corticorelin (DB05394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticotropin-releasing-hormone (CRH) with pre-treatment with dexamethasone
Trial: 15799918
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of platelet hyperreactivity, marginal graft flow, and endothelial disease
Trial: 10924781
Drug: 6 EU
RxNorm normalized name: chlorine dioxide
DrugBank: Chlorine dioxide (DB12453)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 EU vaccine
Trial: 10924781
Drug: 12 EU
RxNorm normalized name: chlorine dioxide
DrugBank: Chlorine dioxide (DB12453)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 EU vaccine
Trial: 10924781
Drug: Reference vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference vaccine